Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Adlard

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Plos One|August 25, 2017
Trehalose improves traumatic brain injury-induced cognitive impairmentStuart D Portbury, Dominic J Hare, David I Finkelstein, et al.
International Journal of Alzheimer'S Disease|August 31, 2011
Copper modulation as a therapy for Alzheimer's disease?Yasmina Manso, Gemma Comes, Juan Hidalgo, et al.
Gene Expression|May 17, 2005
Exercise-induced gene expression changes in the rat spinal cordVictoria M Perreau, Paul A Adlard, Aileen J Anderson, et al.
Frontiers in Aging Neuroscience|November 7, 2014
Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levelsJane M Flinn, P Lorenzo Bozzelli, Paul A Adlard, et al.
Neuroscience Letters|May 26, 2004
The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercisePaul A Adlard, Victoria M Perreau, Christie Engesser-Cesar, et al.
Metallomics : Integrated Biometal Science|January 17, 2013
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicityDominic J Hare, Paul A Adlard, Philip A Doble, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 6, 2009
beta-Amyloid as a molecular therapeutic target in Alzheimer's diseasePaul A Adlard, Simon A James, Ashley I Bush, et al.
Neurobiology of Aging|October 4, 2025
Zinc transporter proteins in the retina as potential biomarkers for staging early Alzheimer's disease: Comparative analysis in human and mouse modelsSeyed Mostafa Hosseinpour Mashkani, David Bishop, Paul A Adlard, et al.
Biochemical and Biophysical Research Communications|May 16, 2019
Extracellular Zn<sup>2+</sup>-independently attenuated LTP by human amyloid β<sub>1-40</sub> and rat amyloid β<sub>1-42</sub>Haruna Tamano, Mako Takiguchi, Ryota Shimaya, et al.
Scientific Reports|April 26, 2019
In vivo synaptic activity-independent co-uptakes of amyloid β<sub>1-42</sub> and Zn<sup>2+</sup> into dentate granule cells in the normal brainHaruna Tamano, Naoya Oneta, Aoi Shioya, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Plos One|August 25, 2017
Trehalose improves traumatic brain injury-induced cognitive impairmentStuart D Portbury, Dominic J Hare, David I Finkelstein, et al.
International Journal of Alzheimer'S Disease|August 31, 2011
Copper modulation as a therapy for Alzheimer's disease?Yasmina Manso, Gemma Comes, Juan Hidalgo, et al.
Gene Expression|May 17, 2005
Exercise-induced gene expression changes in the rat spinal cordVictoria M Perreau, Paul A Adlard, Aileen J Anderson, et al.
Frontiers in Aging Neuroscience|November 7, 2014
Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levelsJane M Flinn, P Lorenzo Bozzelli, Paul A Adlard, et al.
Neuroscience Letters|May 26, 2004
The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercisePaul A Adlard, Victoria M Perreau, Christie Engesser-Cesar, et al.
Metallomics : Integrated Biometal Science|January 17, 2013
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicityDominic J Hare, Paul A Adlard, Philip A Doble, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 6, 2009
beta-Amyloid as a molecular therapeutic target in Alzheimer's diseasePaul A Adlard, Simon A James, Ashley I Bush, et al.
Neurobiology of Aging|October 4, 2025
Zinc transporter proteins in the retina as potential biomarkers for staging early Alzheimer's disease: Comparative analysis in human and mouse modelsSeyed Mostafa Hosseinpour Mashkani, David Bishop, Paul A Adlard, et al.
Biochemical and Biophysical Research Communications|May 16, 2019
Extracellular Zn<sup>2+</sup>-independently attenuated LTP by human amyloid β<sub>1-40</sub> and rat amyloid β<sub>1-42</sub>Haruna Tamano, Mako Takiguchi, Ryota Shimaya, et al.
Scientific Reports|April 26, 2019
In vivo synaptic activity-independent co-uptakes of amyloid β<sub>1-42</sub> and Zn<sup>2+</sup> into dentate granule cells in the normal brainHaruna Tamano, Naoya Oneta, Aoi Shioya, et al.
Pageof 15